HOME >> BIOLOGY >> NEWS
New discovery may help transplants survive

Boston, MA For the first time scientists have found that a growth factor called vascular endothelial growth factor receptor-3 (VEGFR-3), known to cause the growth of lymphatic vessels in the body, controls how immune cells traffic (move) within the eye and also stimulates the immune system to reject corneal transplants--the most common type of transplantation performed. The researchers from the Schepens Eye Research Institute and the Massachusetts Eye and Ear Infirmary, both affiliates of Harvard Medical School, have also found that when this growth factor is blocked, corneal transplants survive. The study, published in the August issue of Nature Medicine, is the first to make a link between VEGEFR-3 and the body's immune response, and may hold significant promise not only for new treatments to prevent transplant rejection but also for diseases such as cancer that may proliferate because of VEGF-3.

"What we have discovered is a previously unknown connection or 'pathway' that stimulates the immune response in the eye and in other parts of the body," says Reza Dana, MD, MPH, a Senior Scientist at the Schepens Eye Research Institute, an Associate Professor and corneal specialist at the Massachusetts Eye and Ear Infirmary and Harvard Medical School, and the senior author of the study.

Each year, nearly 40 thousand Americans receive corneal transplants to replace injured or diseased corneas. Approximately 90 percent of corneal transplants are successful because the eye is intrinsically less likely to reject transplanted material than other parts of the body. However, to suppress rejection of corneal transplants, patients need to use steroid drops which can cause glaucoma, cataract development, and infection -- for years. Even then, many corneal transplants fail, and their failure can cause devastating vision loss. If transplants are placed in eyes suffering from inflammation (caused by a full-blown immune response to the original injury or disease), rej
'"/>

Contact: Patti Jacobs
pjacobs12@comcast.net
627-872-0364
Schepens Eye Research Institute
4-Aug-2004


Page: 1 2 3

Related biology news :

1. Protemix corporation announces discovery of way to repair hearts damaged by diabetes
2. New OHSU lab will speed drug discovery process
3. Genetic discovery could dramatically reduce need for liver transplants in children
4. Plant gene discovery could enhance plant growth, reduce fertilizer needs and phosphate pollution
5. Major scientific discovery in cancer research to be honored
6. New discovery could provide tool to detect whether a cancer will develop and spread
7. UNC research accelerates discovery of novel gene function
8. Tulane opens doors to discovery
9. U. Iowa muscular dystrophy discovery may lead to new treatment approaches
10. Fox Chase discovery may help physicians diagnose, treat devastating childhood disease
11. Maxygen subsidiary Verdia announces discovery and improvement of glyphosate tolerance gene

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/14/2019)... ... February 14, 2019 , ... ... companies from around-the-world and will host 80 scientific sessions and 2,100 presentations. Given ... space, Visikol will feature its OpenLiver™ 3D cell culture model initiative ...
(Date:2/12/2019)... ... February 12, 2019 , ... ... under its new name, KEYLEAF. The company will also shift focus from ... extracts and ingredients as finished products under the new KEYLEAF brand. KEYLEAF ...
(Date:2/2/2019)... ... January 31, 2019 , ... Pharmica Consulting announced it ... executives and focusing on all facets of clinical trial planning and management. ... resource management, patient engagement, and more. , “We have attended the SCOPE ...
Breaking Biology News(10 mins):
(Date:1/30/2019)... ... January 29, 2019 , ... ... Organization (CDMO) serving the global biopharmaceutical and biotechnology industries with sites in China ... backed by multiple global investors lead by China's State Development & Investment Corporation ...
(Date:1/30/2019)... (PRWEB) , ... January 30, 2019 , ... ... experts from pharma, academia and governmental agencies to discuss best practices for laboratory ... from February 4-6. , At this year’s conference, Visikol will be at ...
(Date:1/24/2019)... ... 2019 , ... Dr. Douglas Stramel of Advanced Care Veterinary Services ... (V-PET™) for nearly three years. A proponent of Regenerative Medicine, Dr. Stramel ... began using V-PET™ 2016. V-PET™ is a gravity filtration-based platelet therapy kit that ...
(Date:1/20/2019)... ... 2019 , ... Consumers are directing healthcare in many ways, ... changing as many services now exist for patients to order tests without a ... million in 2018, according to Kalorama Information’s new report, The Direct-To-Consumer Testing ...
Breaking Biology Technology:
Cached News: